{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:35Z","timestamp":1789148975458,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Processa"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jdcr.2020.07.054","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T11:40:50Z","timestamp":1596886850000},"page":"1113-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib"],"prefix":"10.1016","volume":"6","author":[{"given":"Joseph S.","family":"Durgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget E.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2020.07.054_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40257-013-0029-5","article-title":"Etiology, diagnosis, and therapeutic management of granuloma annulare: an update","volume":"14","author":"Thornsberry","year":"2013","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2020.07.054_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaad.2015.03.055","article-title":"Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options","volume":"75","author":"Piette","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2020.07.054_bib3","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jaad.2019.06.1297","article-title":"Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders","volume":"82","author":"Rosenbach","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.07.054_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jdcr.2019.10.016","article-title":"Treatment of granuloma annulare with tofacitinib 2% ointment","volume":"6","author":"Damsky","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jdcr.2020.07.054_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40257-017-0334-5","article-title":"Granuloma annulare: a focused review of therapeutic options","volume":"19","author":"Wang","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.07.054_bib6","first-page":"318","article-title":"The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.07.054_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5021\/ad.2009.21.2.113","article-title":"Clinical and pathological features of generalized granuloma annulare with their correlation: a retrospective multicenter study in Korea","volume":"21","author":"Yun","year":"2009","journal-title":"Ann Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2020.07.054_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jcph.1360","article-title":"Systemic tofacitinib concentrations in adult patients with atopic dermatitis treated with 2% tofacitinib ointment and application to pediatric study planning","volume":"59","author":"Purohit","year":"2019","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.07.054_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2019.12.028","article-title":"Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways","volume":"83","author":"Min","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2020.07.054_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/1040841X.2011.645520","article-title":"Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management","volume":"38","author":"Ilkit","year":"2012","journal-title":"Crit Rev Microbiol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262030583X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262030583X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:15Z","timestamp":1762474935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262030583X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S235251262030583X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.07.054","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}